Sparchez Zeno, Radu Pompilia, Zaharia Teodor, Kacso Gabriel, Diaconu Brîndusa, Grigorescu Ioana, Badea Radu
3rd Medical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Croitorilor 19-21, Romania.
Med Ultrason. 2010 Dec;12(4):286-94.
The ultrasonographic (US) detection of hepatocellular carcinoma (HCC) in patients with liver cirrhosis is based on the visualization of focal lesions. However, in some cases HCC cannot be clearly identified at US, the only sign being a portal vein thrombosis (PVT). Contrast enhanced ultrasound (CEUS) is an excellent method to characterise focal lesions and portal thrombosis in patients with liver cirrhosis. The aim of the study was to assess the value of US and CEUS -guided PVT core biopsy in the diagnosis of an occult HCC in patients with cirrhosis.
Twenty patients with cirrhosis, PVT and no focal lesion on high-resolution US were studied. In 17 cases the thrombus was interpreted as malignant at US. All patients had normal coagulation parameters. The biopsies of an intrahepatic PVT were performed using an 18G Bard needle coupled on "Biopty Gun".US and CEUS guidance was used in16 respectively 4 patients. In 10 cases with a very inhomogeneous hepatic echostructure near the PVT (coarse echo pattern) a liver biopsy from that area was performed.
Adequate histological specimens were obtained in all cases, requiring 1 to 2 passes (mean 1.5 per patient). Only 1 patient had severe pain. No major complications were detected. The overall sensitivity of core biopsy in the diagnosis of malignant PVT was 94.4 % (17/18). The sensitivities of US and CEUS guided PVT biopsy were 92.8% (13/14) and 100% (4/4) respectively. In 6 of 10 cases with coarse echo pattern the same type of HCC was found in the surrounding parenchyma. No false positive results were noted.
US-guided core biopsy of PVT is a safe and useful technique in the diagnosis of occult HCC in cirrhosis and should be performed in all cases with PVT with malignant US features and no evidence of focal lesions. The "coarse echo pattern" found in the vicinity of a malignant thrombus is frequently the expression of an inapparent, occult HCC. CEUS guided PVT biopsy is a new, promising method with excellent results in establishing the nature of a portal thrombus.
肝硬化患者肝细胞癌(HCC)的超声(US)检测基于局灶性病变的可视化。然而,在某些情况下,超声无法清晰识别HCC,唯一的迹象是门静脉血栓形成(PVT)。超声造影(CEUS)是一种用于鉴别肝硬化患者局灶性病变和门静脉血栓形成的优秀方法。本研究的目的是评估超声和CEUS引导下PVT核心活检在肝硬化患者隐匿性HCC诊断中的价值。
研究了20例肝硬化、PVT且高分辨率超声检查无局灶性病变的患者。17例患者的血栓在超声检查中被判定为恶性。所有患者凝血参数均正常。使用与“活检枪”相连的18G巴德针进行肝内PVT活检。16例和4例患者分别采用超声和CEUS引导。10例PVT附近肝实质回声极不均匀(粗回声模式)的患者,对该区域进行了肝活检。
所有病例均获得了足够的组织学标本,穿刺1至2次(平均每位患者1.5次)。仅1例患者出现严重疼痛。未检测到重大并发症。核心活检诊断恶性PVT的总体敏感性为94.4%(17/18)。超声和CEUS引导下PVT活检的敏感性分别为92.8%(13/14)和100%(4/4)。10例粗回声模式患者中有6例在周围实质中发现了相同类型的HCC。未发现假阳性结果。
超声引导下PVT核心活检是诊断肝硬化隐匿性HCC的一种安全有效的技术,应在所有具有恶性超声特征且无局灶性病变证据的PVT病例中进行。恶性血栓附近发现的“粗回声模式”通常是隐匿性HCC的表现。CEUS引导下PVT活检是一种新的、有前景的方法,在确定门静脉血栓性质方面效果极佳。